Totipotent stem cells (TSCs) are early embryonic stem cells characterized by their ability to differentiate into any cell in the body¹.

Totipotent stem cells can give rise to all embryonic and extra-embryonic tissues, including the trophectoderm, which forms the placenta and other structures essential for embryonic development. Their unique epigenetic and transcriptional profiles allow them to generate an entire organism, making them a fundamental focus in developmental biology. Totipotency is critical during the earliest stages of life, specifically in the zygote and the blastomeres of the 2-cell and, in some cases, 4-cell stage embryos, where each cell retains the ability to develop into both the embryo proper and supporting tissues. Beyond these stages, cells typically lose totipotency and become pluripotent, limiting their developmental potential.

Totipotent stem cells hold significant value in scientific research for their potential applications in regenerative medicine, developmental biology, and therapeutic cloning. Understanding their molecular regulation could lead to advances in tissue engineering and disease modeling. However, isolating and maintaining totipotent cells in vitro remains technically challenging, and their use raises ethical concerns, particularly regarding the creation and manipulation of early human embryos.

Key features of totipotent stem cells

Potency and differentiation:

Totipotent stem cells have the highest potential for differentiation and can differentiate into all types of cells within the organism, including both extra-embryonic and embryonic tissues². Their excellent potency is vital in the early phases of development, particularly after fertilization.

In mammals, this totipotency is strictly limited to the zygote and the first few divisions (2-cell and sometimes 4-cell stage). After these early stages, cells lose totipotency and transition to pluripotency, meaning they can no longer form extra-embryonic tissues like the placenta³. Totipotent cells are the only cells capable of giving rise to a complete organism when isolated and implanted in a suitable environment.

Self-replication:

The totipotent stem cells undergo self-replication, meaning they possess the ability to produce daughter cells that are identical to the parent cell. This property ensures a continuous supply of stem cells for developmental processes and tissue regeneration. Found in the earliest stages of embryonic development, totipotent stem cells can give rise to all cell types, including extraembryonic tissues like the placenta. Their self-renewing capacity is tightly regulated to maintain a balance between proliferation and differentiation. This unique characteristic holds great promise for regenerative medicine and therapeutic cloning, offering potential pathways to repair damaged tissues or even generate entire organs.

The self-renewal capacity of totipotent cells is limited in vivo, as they rapidly begin to differentiate during embryogenesis⁴. In contrast to pluripotent stem cells, stable long-term cultures of totipotent stem cells have not yet been established in vitro.

Germ line:

The totipotent stem cells possess the ability to enter the germ line, meaning they can transfer genetic material from the parent to the daughter cells. Entry into the germ line is essential for the continuation of genetic information across generations. Totipotent cells give rise to both somatic cells and germ cells (sperm or eggs), ensuring the propagation of the species.

Comparison with other stem cell types

Totipotent stem cells differ significantly from pluripotent and multipotent stem cells in terms of their potency.

Pluripotent stem cells derived from the inner cell mass of the blastocyst possess the ability to bring about the transformation of cells that are formed from the germ layer, like the ectoderm, mesoderm, and endoderm, followed by their differentiation into tissues and organs. They do not possess the ability to bring about the formation of extraembryonic structures such as the placenta. Multipotent stem cells, such as hematopoietic stem cells, possess the ability to self-renew and differentiate into specialized types of cells within specific organs or tissues. They are important components for protection, development, and tissue repair.

In contrast, totipotent stem cells are the only cells that can generate both the embryo and all supporting extra-embryonic structures required for full organismal development. The ability to form a complete organism (including placenta) is the defining test of totipotency, often assessed by single-cell embryo transfer experiments in animal models.

Contribution of totipotent stem cells to embryonic development

Totipotent stem cells play an important role in the early stages of development, immediately following fertilization. These cells are important in producing both the embryo and the supporting structures that enable the embryo to thrive, underscoring the significance and impact of research in this field.

Presence in early development

Totipotent stem cells are observed immediately after the egg is fertilized. The zygote is a single cell generated by the combination of sperm and egg and is classified as totipotent because it can divide and differentiate into all of the cell types required to form a whole organism. As the zygote divides, it generates the morula, which is composed of totipotent cells.

In mammals, true totipotency is present in the zygote and persists through the 2-cell and sometimes the 4-cell stage. After the morula stage (typically around the 8-cell stage in humans), cells begin to specialize and lose totipotency, transitioning to a pluripotent state^5,6. The morula is a solid ball of cells; at this point, each blastomere is still capable of developing into a complete organism if separated and implanted in a suitable environment (demonstrated in animal models).

Formation of the embryo and placenta

During early embryonic development, totipotent cells produce both the inner cell mass, which subsequently develops into the embryo, and the trophoblast, followed by the formation of the placenta. The ability of totipotent cells to contribute to both of these essential tissues emphasizes their importance in ensuring proper embryo implantation into the uterine wall and the commencement of development. Defects in the function or differentiation of totipotent cells can result in failed implantation or early embryonic loss.

Developmental potential

Totipotent stem cells have the highest developmental potential and the unique ability to produce any sort of tissue, embryonic or extra-embryonic. As the organism develops, cells lose totipotency and become pluripotent, multipotent, or unipotent, which means they can only differentiate into specific cell types. The change from totipotency to pluripotency is a critical stage in development.

The transition from totipotency to pluripotency is regulated by changes in gene expression and epigenetic modifications, including DNA methylation and histone modification⁷. Pluripotent cells, such as those in the inner cell mass, can form all body tissues but not the placenta or other extra-embryonic tissues. Multipotent and unipotent cells arise later and are restricted to specific lineages or cell types.

Differentiation of totipotent stem cells

The differentiation of totipotent stem cells is a highly regulated process that begins shortly after fertilization. These cells divide and differentiate to give rise to the various cell types that make up an entire organism.

The differentiation process

Totipotent stem cells appear identical at first and can give rise to every cell type in the body. As development advances, these cells specialize, and their potency gradually declines. Key transcription factors (such as Oct4, Sox2, and Nanog) become upregulated as cells lose totipotency and acquire pluripotency⁸. The first major differentiation event is the segregation of the inner cell mass (which becomes the embryo) and the trophectoderm (which contributes to extra-embryonic tissues).

Developmental stages of differentiation

A network of genetic and molecular signals carefully controls the stages of differentiation. For example, the inner cell mass of the early embryo will give rise to pluripotent stem cells, which can later differentiate into any cell type in the body. Meanwhile, the outer cells (trophectoderm) of the embryo will contribute to the placenta.

Examples of differentiated cell types

• Embryonic cells: These will eventually form various tissues, including skin, muscle, and neural tissue⁹.
• Extra-embryonic cells: These include trophoblast cells, which will form the placenta and provide nutrients to the developing embryo¹⁰. Other extra-embryonic tissues derived from totipotent cells include the yolk sac and amniotic membrane.

Embryonic derivatives ultimately give rise to all organs and tissues in the body, while extra-embryonic derivatives are essential for implantation, nutrient exchange, and protection of the embryo. In experimental models (such as mouse embryos), isolated totipotent cells have been shown to generate a complete organism, confirming their full developmental potential.

Sources of totipotent stem cells

Totipotent stem cells can be derived from both natural sources and artificial means. The most common sources of totipotent stem cells are embryos, but new developments in stem cell reprogramming have recently allowed the possibility of generating totipotent-like cells from adult tissues.

Natural sources

Totipotent stem cells appear spontaneously in the early phases of embryonic development. In mice, totipotent cells exist at the zygote stage right after fertilization and can differentiate into any cell type, including body tissues and placental cells. These cells are critical to the development of the entire organism. Mouse embryonic stem cells produced from this early stage are useful in research, notably in studies of cellular differentiation, developmental biology, and disease models.

Similarly, during early development, human zygotes include totipotent stem cells capable of producing all the tissues required to make a complete organism. These totipotent cells are critical to understanding human development and the processes that control cellular specialization and embryonic growth.

In mammals, true totipotency is limited to the zygote and the first few cleavage divisions (2-cell and sometimes 4-cell stages). The morula stage contains cells that are still totipotent or nearly totipotent, but by the blastocyst stage, cells have largely lost totipotency and become pluripotent¹¹. Mouse embryonic stem cells (mESCs) are typically derived from the inner cell mass of the blastocyst and are pluripotent, not totipotent; however, early blastomeres before the blastocyst stage retain totipotency. The scarcity and transient nature of totipotent cells in vivo make their isolation and study challenging.

Induced totipotent stem cells

Induced totipotent stem cells (iTSCs) are generated through reprogramming techniques that often involve the introduction of transcription factors or chemical compounds to reset the epigenetic state of somatic cells, such as skin cells, to become totipotent¹². While totipotent stem cells emerge naturally throughout early development, iTSCs are created by altering gene expression to restore pluripotency. Though iTSCs can develop into actual totipotent cells, the reprogramming process may only partially duplicate the biological functions and stability of naturally occurring totipotent cells. Research into iTSCs holds promise for overcoming ethical issues related to embryo use and for advancing regenerative medicine by providing a potentially unlimited source of totipotent cells. Challenges include ensuring genomic stability, full developmental potential, and reproducibility of iTSCs.

Applications of totipotent stem cells

Regenerative medicine and tissue repair:

The prospect of utilizing totipotent cells to generate both embryonic and extra-embryonic tissues and produce entire organs or complex tissue structures offers a promising future in the treatment of serious injuries, degenerative diseases, or organ failure¹³. While still largely in experimental stages, totipotent stem cells could overcome limitations related to tissue integration and vascularization, allowing for personalized regenerative treatments. However, significant ethical and technical challenges must be addressed before totipotent stem cells can be widely used in medicine. These challenges include the precise control of differentiation, ensuring immune compatibility, and avoiding tumorigenesis.

Research in developmental biology:

Totipotent stem cells can help comprehend the mechanism of an organism’s growth from a single fertilized egg to a complex multicellular entity. The pathways associated with cell differentiation can provide information on developmental and disease mechanisms.

Studying totipotent cells helps elucidate early gene regulatory networks, epigenetic reprogramming, and cell fate decisions. Insights gained can improve understanding of congenital disorders, infertility, and early pregnancy loss¹⁴. Totipotent stem cells serve as models to study the effects of genetic mutations and environmental factors on early development.

Medical applications

Though their direct clinical application is still in the early stages, totipotent stem cells have a wide range of medical applications.

• TSCs have the potential to treat a wide range of ailments, including liver disorders, cardiovascular disease, retinal disease, and neurodegenerative disorders^15,16,17.
• TSCs also serve an important role in medication screening, allowing researchers to assess the safety and efficacy of novel treatments.
• Furthermore, they can be utilized to develop individualized medicines based on individual genetic profiles.
• TSCs have shown promise in regenerative medicine for tissue and organ restoration.
• They are instrumental in mammalian breeding and conservation efforts since TSCs can produce blastocyst-like structures, potentially resulting in synthetic embryos for species preservation and research.
• The ability of totipotent stem cells to generate extra-embryonic tissues opens possibilities for creating synthetic embryos, which could revolutionize reproductive technologies and conservation biology¹³.
• Personalized medicine applications include generating patient-specific cells for drug testing and disease modeling.
• Ethical and safety considerations remain significant barriers to clinical translation¹⁸.

Ethical and regulatory considerations

The use of totipotent stem cells raises ethical and regulatory concerns, particularly regarding the development and destruction of embryos for research purposes.

Ethical issues

The ethics of totipotent stem cells center on human embryos. Most individuals consider the use of human embryos in research to be a moral concern because it destroys the embryos, while others believe that the possible medical advantages justify it. This sparks debate about the moral status of the embryo, with some viewing it as having full human rights from conception, while others consider it a cluster of cells until later developmental milestones. Additionally, concerns exist about the potential for human cloning or misuse in genetic modification. Ethical frameworks such as the “14-day rule” limit research on human embryos beyond 14 days post-fertilization, when the primitive streak forms, marking the beginning of individual development¹⁹. These ethical considerations continue to spark debate in scientific, religious, and political circles. International organizations like the International Society for Stem Cell Research (ISSCR) provide guidelines to ensure ethical conduct in stem cell research²⁰. While the scientific potential is vast, ethical considerations call for strict regulation, transparency, and ongoing public discourse to balance progress with morality.

Public perception and policy

Public perception of stem cell research, including the use of totipotent stem cells, plays a critical role in shaping policy and funding decisions. Policies vary significantly across countries, with some banning embryonic stem cell research while others support it under strict regulations. Public opinion can shift with education and awareness of the scientific benefits and ethical safeguards. Public debates and evolving scientific advancements continue to shape policy decisions, highlighting the importance of transparent communication and responsible innovation.

Countries such as Germany and Italy have restrictive laws on embryonic stem cell research, while the UK and Canada allow regulated research under licensing systems²¹. Public education campaigns and media coverage influence acceptance and support for stem cell research. Ethical controversies have led to fluctuating funding levels and political support in various regions. Engaging diverse stakeholders, including ethicists, scientists, policymakers, and the public, is essential for informed policymaking.

Regulations and laws

Stem cell research operates under strict ethical and regulatory frameworks. For example, in the United States, the use of totipotent stem cells for research purposes must be approved by institutional review boards and must adhere to human embryo-use regulations. The U.S. federal government restricts funding for research involving the creation or destruction of human embryos through the Dickey-Wicker amendment, but allows privately funded research under certain conditions²¹. The European Union enforces strict guidelines, with some member states banning such research altogether. In contrast, countries like the United Kingdom allow regulated research under licenses.

Human totipotent cells are not patentable because the human body at various stages of its formation and development is excluded from patentability²². This aligns with the European Court of Justice’s ruling against patenting inventions involving human embryos, reflecting ethical concerns²³. National regulations often require informed consent from donors of embryos or gametes used in research²⁴. These laws strive to balance scientific progress with ethical concerns, ensuring that stem cell research respects human dignity and rights.

Technical challenges in research

Isolating and maintaining totipotent stem cells in a laboratory poses considerable obstacles. These cells are extremely sensitive and require precise conditions to maintain viability in vitro. Because they can develop into all cell types, they can quickly lose totipotency under inadequate conditions.

Totipotent stem cells exist only transiently in vivo, primarily in the zygote and early cleavage stages (2-cell to 4-cell), making their isolation inherently difficult¹. Furthermore, maintaining their undifferentiated condition requires initiating early developmental phases, as totipotent cells spontaneously differentiate immediately after fertilization. These obstacles make it challenging to investigate and utilize their full therapeutic potential.

In vitro culture systems that can reliably sustain totipotency over extended periods have not yet been fully established, unlike pluripotent stem cells, which can be cultured long-term. The primary reason for this is the seemingly slow growth rate observed in all totipotent stem cells reported to date²⁵. Moreover, the microenvironment or “niche” that supports totipotency in vivo involves complex signaling pathways and epigenetic states that are challenging to replicate in vitro. For example, precise control of growth factors, extracellular matrix components, oxygen tension, and nutrient supply is needed to prevent spontaneous differentiation and maintain totipotency.

Genetic and epigenetic instability during culture can lead to loss of totipotency or unwanted differentiation, complicating their use in research and therapy²⁵. Additionally, totipotent-like cells generated through reprogramming methods, such as induced totipotent stem cells, often display incomplete reprogramming and variability in developmental potential compared to authentic totipotent cells. Even promising new models like totipotent blastomere-like cells (TBLCs) and totipotent-like stem cells (TLSCs) show limitations in proliferation, stability, and the ability to develop into a whole organism under current conditions¹³.

Ethical and regulatory constraints on working with early human embryos further limit experimental approaches to study and manipulate totipotent cells, especially for gold-standard functional assays such as blastoid formation and chimera generation, which cannot be ethically performed in humans.

These technical challenges necessitate ongoing research to develop optimized culture systems, better molecular markers for totipotency, and safer reprogramming techniques. Advances in high-throughput screening, artificial intelligence-driven optimization, and improved reporter systems are expected to accelerate progress in capturing and harnessing the full potential of totipotent stem cells for medicine and biology.

Future directions in totipotent stem cell research

The future of totipotent stem cell research is full of promising prospects. As the understanding of these cells continues to deepen, new technologies and methods are expected to emerge that can overcome many of the challenges currently faced by researchers.

Emerging technologies

Advances in gene editing, such as CRISPR-Cas9, offer exciting prospects for enhancing the ability of totipotent stem cells to regenerate tissues or treat genetic disorders²⁶. These technologies enable more precise control over cell differentiation and may increase the safety and efficacy of stem cell-based therapies. In addition, the integration of bioengineering, advanced imaging, and high-throughput screening technologies is expected to accelerate the development of optimized protocols for culturing and manipulating totipotent cells.

Recent progress in single-cell sequencing and molecular profiling is also providing deeper insights into the gene regulatory networks and epigenetic landscapes that distinguish totipotent cells from pluripotent and multipotent stem cells²⁷. This molecular understanding will be crucial for developing methods to maintain or induce totipotency in vitro.

Potential breakthroughs

The ability to generate totipotent-like cells from adult tissues could lead to significant breakthroughs in personalized medicine, providing patients with custom-tailored therapies derived from their cells. Such advances could reduce the risk of immune rejection and allow for the creation of patient-specific tissues or even organs for transplantation²⁸.

Emerging applications include synthetic embryo-like models and multi-lineage organoids for disease modeling, drug discovery, and developmental studies. Notably, reprogrammed human totipotent cells can self-organize into blastocyst-like “blastoids,” which recapitulate key features of early human development and provide powerful new tools for research²⁹.

Personalized medicine approaches, powered by totipotent stem cell technology, could allow for individualized drug testing and gene correction, optimizing treatments for each patient’s unique genetic makeup³⁰. This approach is expected to transform the way diseases are modeled and treated, making therapies more effective and reducing adverse effects.

Despite these advances, challenges remain in 3precisely controlling the differentiation of totipotent cells, ensuring their safety, and addressing ethical concerns related to the creation and use of human embryo-like constructs. The risk of tumorigenesis, genetic instability, and incomplete reprogramming must be addressed before clinical translation can be realized.

FAQs

How do totipotent stem cells differ from pluripotent stem cells?

Totipotent stem cells and pluripotent stem cells have different developmental capacities. Totipotent cells can create all cell types in an organism, including extra-embryonic tissues, whereas pluripotent cells can differentiate into any cell type except extra-embryonic tissues.

What role do totipotent stem cells play in human development?

Totipotent stem cells are critical for early human development because they can differentiate into any type of cell, including extra-embryonic tissues such as the placenta and body tissues. They are essential in the development of the embryo and the structures that support it, as well as the overall growth of the body in the early stages after fertilization.

Where are totipotent stem cells found?

Totipotent cells exist naturally only for a short time in human development. They are found in the zygote, which is the single cell formed immediately after fertilization of the egg by the sperm. As the zygote begins dividing, the first few cells (up to about the 8-cell stage, roughly 3 days post-fertilization) retain totipotency. After this point, the cells begin to specialize and lose totipotency, becoming pluripotent instead.

Why are totipotent stem cells important?

Totipotent stem cells are essential for understanding early embryonic development, cell differentiation, and the origins of life. They also offer potential applications in cloning technologies, improving our knowledge of miscarriages and developmental defects, and advancing regenerative medicine by uncovering how cells become specialized. Although their use remains highly limited at present, studying totipotent stem cells could revolutionize our understanding of human development and lead to new approaches for treating various diseases.

What is an example of a totipotent cell?

The most well-known and universally accepted example of a totipotent cell is the zygote, the single-cell organism formed by the fusion of an egg and a sperm. The first few cells produced by the zygote’s division (up to the 8-cell stage) are also considered totipotent. Each of these cells, in theory, has the potential to form a complete human being and supporting tissues.

What is the future of totipotent stem cell research?

The future of totipotent stem cell research holds great promise, with potential to deepen our understanding of early human development, improve IVF and fertility treatments, advance regenerative therapies, and refine cloning and cellular reprogramming techniques. Additionally, scientists are working to create synthetic totipotent-like cells that do not involve the use of embryos, an approach that could circumvent ethical concerns and open new avenues in developmental biology and medicine.

References:

1. Malik, V., and Wang, J. Pursuing totipotency: authentic totipotent stem cells in culture. Trends in Genetics. 38, 632-636 (2022).

2. Ghazimoradi, M. H., Khalafizadeh, A., and Babashah, S. A critical review on induced totipotent stem cells: Types and methods. Stem cell research. 63, 102857 (2022).

3. Boroviak, T., and Nichols, J. The birth of embryonic pluripotency. Philosophical Transactions of the Royal Society B: Biological Sciences. 369, 20130541 (2014).

4. Du, P., and Wu, J. Hallmarks of totipotent and pluripotent stem cell states. Cell Stem Cell. 31, 312-333 (2024).

5. Los, F. J., Van Opstal, D., and van den Berg, C. The development of cytogenetically normal, abnormal and mosaic embryos: a theoretical model. Human reproduction update. 10, 79-94 (2004).

6. Morgani, S. M., and Brickman, J. M. The molecular underpinnings of totipotency. Philosophical Transactions of the Royal Society B: Biological Sciences. 369, 20130549 (2014).

7. Surani, M. A., Hayashi, K., and Hajkova, P. Genetic and epigenetic regulators of pluripotency. Cell. 128, 747-762 (2007).

8. Geng, T., Zhang, D., and Jiang, W. Epigenetic regulation of transition among different pluripotent states: concise review. Stem cells. 37, 1372-1380 (2019).

9. Rippon, H. J., and Bishop, A. E. Embryonic stem cells. Cell proliferation. 37, 23-34 (2004).

10. Ren, H., Jia, X., and Yu, L. The building blocks of embryo models: embryonic and extraembryonic stem cells. Cell Discovery. 11, 40 (2025).

11. Lu, F., and Zhang, Y. Cell totipotency: molecular features, induction, and maintenance. National science review. 2, 217-225 (2015).

12. Ghazimoradi, M. H., Khalafizadeh, A., and Babashah, S. A critical review on induced totipotent stem cells: Types and methods. Stem cell research. 63, 102857 (2022).

13. Cai, J., Chen, H., Xie, S., et al. Research progress of totipotent stem cells. Stem cells and development. 31, 335-345 (2022).

14. Anna, S., Agnieszka, M., Olga, N., et al. Turner syndrome: the promise of fertility via stem cell technology. Hormones. 1-11 (2025).

15. Lovell, M. J., and Mathur, A. The role of stem cells for treatment of cardiovascular disease. Cell proliferation. 37, 67-87 (2004).

16. Luo, M., and Chen, Y. Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future. International journal of ophthalmology. 11, 150 (2018).

17. Poliwoda, S., Noor, N., Downs, E., et al. Stem cells: a comprehensive review of origins and emerging clinical roles in medical practice. Orthopedic reviews. 14, 37498 (2022).

18. Aly, R. M. Current state of stem cell-based therapies: an overview. Stem cell investigation. 7, 8 (2020).

19. Pera, M. F. Human embryo research and the 14-day rule. Development. 144, 1923-1925 (2017).

20. Ludwig, T. E., Andrews, P. W., Barbaric, I., et al. ISSCR standards for the use of human stem cells in basic research. Stem cell reports. 18, 1744-1752 (2023).

21. Matthews, K. R., and Moralí, D. National human embryo and embryoid research policies: a survey of 22 top research-intensive countries. Regenerative medicine. 15, 1905-1917 (2020).

22. Statutory guidance: Inventions involving human embryonic stem cells. UK Government. 25 March 2015.

23. Nielen, M. G., De Vries, S. A., and Geijsen, N. European stem cell research in legal shackles. The EMBO Journal. 32, 3107-3111 (2013).

24. Busardò, F. P., Gulino, M., Napoletano, S., et al. The evolution of legislation in the field of Medically Assisted Reproduction and embryo stem cell research in European union members. BioMed research international. 2014, 307160 (2014).

25. Du, P., and Wu, J. Hallmarks of totipotent and pluripotent stem cell states. Cell Stem Cell. 31, 312-333 (2024).

26. Jiang, F., and Doudna, J. A. CRISPR–Cas9 structures and mechanisms. Annual review of biophysics. 46, 505-529 (2017).

27. Hu, Y., Yang, Y., Tan, P., et al. Induction of mouse totipotent stem cells by a defined chemical cocktail. Nature. 617, 792-797 (2023).

28. Fu, S., and Zarrinpar, A. Recent advances in precision medicine for individualized immunosuppression. Current opinion in organ transplantation. 25, 420-425 (2020).

29. Lüttmann, F. F., Kim, K. P., and Kim, J. Spliceosomal repression: unleashing human cell totipotency. Signal Transduction and Targeted Therapy. 9, 251 (2024).

30. Liu, M., Yang, F., and Xu, Y. Global trends of stem cell precision medicine research (2018–2022): A bibliometric analysis. Frontiers in Surgery. 9, 888956 (2022).